newsroom.thermofisher.com/newsroom/press-releases/press-release-details/2024/Thermo-Fisher-Scientific-Completes-Acquisition-of-Olink-Announces-Commencement-of-Subsequent-Offering-Period/default.aspx
Preview meta tags from the newsroom.thermofisher.com website.
Linked Hostnames
15- 9 links tonewsroom.thermofisher.com
- 9 links towww.thermofisher.com
- 8 links tocorporate.thermofisher.com
- 8 links tocts.businesswire.com
- 2 links toir.thermofisher.com
- 1 link tobusinesswire.com
- 1 link toc212.net
- 1 link tojobs.thermofisher.com
Search Engine Appearance
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
Subsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment. “We are excited to welcome Olink colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine. Olink’s proven and transformative solutions for proteomics are highly complementary to our leading mass spectrometry and life sciences offerings. By expanding our capabilities in the high-growth
Bing
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
Subsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment. “We are excited to welcome Olink colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine. Olink’s proven and transformative solutions for proteomics are highly complementary to our leading mass spectrometry and life sciences offerings. By expanding our capabilities in the high-growth
DuckDuckGo
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
Subsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment. “We are excited to welcome Olink colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine. Olink’s proven and transformative solutions for proteomics are highly complementary to our leading mass spectrometry and life sciences offerings. By expanding our capabilities in the high-growth
General Meta Tags
7- titleThermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period | Newsroom | Thermo Fisher Scientific
- Content-typetext/html; charset=UTF-8
- Page-EnterRevealTrans(Duration=0,Transition=0)
- X-UA-CompatibleIE=edge,chrome=1
- viewportwidth=device-width, initial-scale=1
Open Graph Meta Tags
4- og:titleThermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
- descriptionSubsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment. “We are excited to welcome Olink colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine. Olink’s proven and transformative solutions for proteomics are highly complementary to our leading mass spectrometry and life sciences offerings. By expanding our capabilities in the high-growth
- og:typewebsite
- og:urlhttps://newsroom.thermofisher.com/newsroom/press-releases/press-release-details/2024/Thermo-Fisher-Scientific-Completes-Acquisition-of-Olink-Announces-Commencement-of-Subsequent-Offering-Period/default.aspx
Twitter Meta Tags
2- twitter:titleThermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
- twitter:descriptionSubsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment. “We are excited to welcome Olink colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine. Olink’s proven and transformative solutions for proteomics are highly complementary to our leading mass spectrometry and life sciences offerings. By expanding our capabilities in the high-growth
Link Tags
9- icon//s201.q4cdn.com/585561171/files/favicon.ico
- shortcut icon//s201.q4cdn.com/585561171/files/favicon.ico
- stylesheet//s201.q4cdn.com/585561171/files/css/print.css
- stylesheet//s201.q4cdn.com/585561171/files/css/global.css?v=41567
- stylesheet//s201.q4cdn.com/585561171/files/css/client.css?v=41597
Emails
3Links
46- http://businesswire.com
- http://ir.thermofisher.com
- https://c212.net/c/link/?t=0&l=en&o=3133871-1&h=3729062255&u=http%3A%2F%2Fwww.thermofisher.com%2F&a=www.thermofisher.com
- https://corporate.thermofisher.com/content/tfcorpsite/us/en/index/newsroom/thought-leadership.html
- https://corporate.thermofisher.com/us/en/index.html